Status:
COMPLETED
Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
Schizophrenia Schizoaffective
Eligibility:
All Genders
22-85 years
Phase:
NA
Brief Summary
In a randomized controlled design with approximately 26 biweekly sessions over 12 months, the investigators propose to test the effectiveness of an ECHO-based intervention for improving the use of clo...
Eligibility Criteria
Inclusion
- Located at a site in the State of Maryland with at least 3 prescribers at the site.
- Prescribers/clinical team should be licensed in the State of Maryland and have prescribed antipsychotics previously.
- Between the ages of 22 and 85 years old
- Willing to participate in pre- and post-testing
- Willing to agree to try to participate in the CHAMPION sessions
Exclusion
- Not willing to participate in CHAMPION Sessions
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2024
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT04325386
Start Date
February 1 2020
End Date
September 20 2024
Last Update
August 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maryland Psychiatric Research Center (MPRC) Treatment Research Program (TRP)
Catonsville, Maryland, United States, 21228